Jaishri O Blakeley Selected Research

Nerve Sheath Neoplasms (Nerve Sheath Neoplasm)

10/2019	Imaging biomarkers for malignant peripheral nerve sheath tumors in neurofibromatosis type 1.
10/2017	The efficacy of lapatinib and nilotinib in combination with radiation therapy in a model of NF2 associated peripheral schwannoma.
10/2016	Multiparametric whole-body anatomic, functional, and metabolic imaging characteristics of peripheral lesions in patients with schwannomatosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jaishri O Blakeley Research Topics

Disease

41	Neoplasms (Cancer) 11/2022 - 11/2006
16	Glioma (Gliomas) 06/2022 - 01/2009
12	Neurofibromatosis 1 (Neurofibromatosis Type I) 11/2022 - 03/2015
10	Neurofibromatosis 2 (Neurofibromatosis Type II) 01/2022 - 05/2009
10	Neurofibromatoses (Neurofibromatosis) 10/2021 - 02/2010
8	Schwannomatosis 01/2022 - 03/2013
7	Brain Neoplasms (Brain Tumor) 01/2022 - 10/2008
5	Plexiform Neurofibroma 11/2022 - 01/2020
5	Meningioma (Meningiomas) 10/2021 - 06/2017
5	Glioblastoma (Glioblastoma Multiforme) 01/2021 - 07/2012
4	Neurofibrosarcoma (MPNST) 06/2022 - 10/2019
4	Acoustic Neuroma (Acoustic Neurinoma) 10/2021 - 05/2009
4	Neurilemmoma (Schwannoma) 01/2021 - 10/2017
3	Nerve Sheath Neoplasms (Nerve Sheath Neoplasm) 10/2019 - 10/2016
2	Ketosis 01/2021 - 09/2015
2	Sarcoma (Soft Tissue Sarcoma) 01/2020 - 06/2017
2	Exanthema (Rash) 01/2020 - 01/2019
2	Neurofibroma 12/2019 - 10/2018
2	Carcinogenesis 12/2019 - 01/2018
2	Breast Neoplasms (Breast Cancer) 01/2018 - 12/2012
1	Cancer Pain 11/2022
1	Astrocytoma (Pilocytic Astrocytoma) 01/2021
1	Fatigue 01/2021
1	Hypothyroidism 01/2021
1	Pain (Aches) 01/2021
1	Central Nervous System Neoplasms 02/2020
1	Paronychia 01/2020
1	Nausea 01/2020
1	Rare Diseases (Rare Disease) 01/2020
1	Diarrhea 01/2020
1	Peripheral Nervous System Neoplasms 01/2020
1	Disease Progression 01/2020
1	Vomiting 01/2020
1	Asthma (Bronchial Asthma) 12/2019
1	Allergic Conjunctivitis (Giant Papillary Conjunctivitis) 12/2019
1	Epilepsy (Aura) 07/2019
1	Inflammation (Inflammations) 07/2019
1	Thrombocytopenia (Thrombopenia) 01/2019
1	Gastritis 01/2019
1	Tinnitus 01/2018

Drug/Important Bio-Agent (IBA)

13	Pharmaceutical PreparationsIBA 10/2021 - 01/2009
9	Biomarkers (Surrogate Marker)IBA 01/2022 - 11/2012
8	Temozolomide (Temodar)FDA LinkGeneric 06/2022 - 09/2011
7	Uvitex SWN (SWN)IBA 01/2022 - 01/2016
6	AmidesIBA 01/2022 - 10/2008
6	Protons (Proton)IBA 01/2022 - 10/2008
4	APTIBA 01/2022 - 10/2008
4	Bevacizumab (Avastin)FDA Link 01/2018 - 07/2012
3	AZD 6244IBA 11/2022 - 01/2020
3	Biological ProductsIBA 01/2021 - 01/2020
3	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 10/2019 - 03/2015
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 11/2022 - 06/2022
2	Everolimus FDA Link 01/2021 - 10/2017
2	CytokinesIBA 01/2021 - 07/2019
2	ProdrugsIBA 01/2020 - 10/2015
2	iniparibIBA 01/2019 - 10/2015
2	GadoliniumIBA 11/2013 - 10/2008
2	Methotrexate (Mexate)FDA LinkGeneric 12/2012 - 01/2009
2	Antineoplastic Agents (Antineoplastics)IBA 09/2011 - 05/2009
1	telomerase RNA (bTR)IBA 06/2022
1	Histone Deacetylase InhibitorsIBA 10/2021
1	brigatinibIBA 01/2021
1	cabozantinibIBA 01/2021
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2021
1	AnthelminticsIBA 01/2021
1	Indicators and Reagents (Reagents)IBA 01/2021
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2021
1	KetonesIBA 01/2021
1	Mebendazole (Anti-Worm)FDA Link 01/2021
1	Phosphotransferases (Kinase)IBA 01/2021
1	Tyrosine (L-Tyrosine)FDA Link 01/2021
1	Glutamine (L-Glutamine)FDA Link 01/2020
1	antineoplaston A10 (A 10)IBA 01/2020
1	Creatine Kinase (Creatine Phosphokinase)IBA 01/2020
1	NitrogenIBA 01/2020
1	purineIBA 01/2020
1	IsotopesIBA 01/2020
1	CarbonIBA 01/2020
1	Imatinib Mesylate (Gleevec)FDA Link 01/2020
1	JHU395IBA 01/2020
1	Stem Cell FactorIBA 12/2019
1	Ketotifen (Ketotifene)FDA Link 12/2019
1	EnzymesIBA 01/2019
1	Messenger RNA (mRNA)IBA 10/2018
1	Proteins (Proteins, Gene)FDA Link 10/2018
1	PanobinostatIBA 01/2018
1	omipalisibIBA 01/2018
1	Drug CombinationsIBA 01/2018
1	DNA (Deoxyribonucleic Acid)IBA 01/2018
1	Neurofibromin 2 (Merlin)IBA 01/2018
1	RNA (Ribonucleic Acid)IBA 01/2018
1	nilotinib FDA Link 10/2017
1	Lapatinib (GW572016)FDA Link 10/2017

Therapy/Procedure

19	Therapeutics 11/2022 - 11/2006
6	Drug Therapy (Chemotherapy) 07/2019 - 02/2010
5	Radiotherapy 01/2019 - 11/2006
4	Aftercare (After-Treatment) 01/2019 - 10/2017
3	Adjuvant Chemotherapy 01/2021 - 11/2006
1	Drug Tapering 01/2021
1	Ketogenic Diet 07/2019